PedAM
Pediatric Disease Annotations & Medicines
| Disease | eisenmenger syndrome |
| Phenotype | C1619734|pulmonary arterial hypertension |
| Sentences | 3 |
| PubMedID- 25787798 | Previous studies examining the use of pulmonary arterial hypertension (pah) drugs in patients with eisenmenger syndrome (es) have shown that it may have beneficial effects in some patients with es; however, experience with additional cases is necessary to confirm its efficacy and appropriate clinical use. |
| PubMedID- 20026774 | Background: advanced therapy (at) for pulmonary arterial hypertension in the context of congenital heart disease (eisenmenger syndrome) improves pulmonary hemodynamics, functional class, and the 6-minute walk test. |
| PubMedID- 21943933 | The dual endothelin receptor antagonist, bosentan, has been shown to be well tolerated and effective in improving pulmonary arterial hypertension (pah) symptoms in patients with eisenmenger syndrome but data from longer-term studies are lacking. |
Page: 1